Dnmt3arestrains mast cell inflammatory responses.
DNA methylation and specifically the DNA methyltransferase enzyme DNMT3A are involved in the pathogenesis of a variety of hematological diseases and in regulating the function of immune cells. Although altered DNA methylation patterns and mutations inDNMT3Acorrelate with mast cell proliferative disorders in humans, the role of DNA methylation in mast cell biology is not understood. By using mast cells lackingDnmt3a, we found that this enzyme is involved in restraining mast cell responses to acute and chronic stimuli, both in vitro and in vivo. The exacerbated mast cell responses observed in the absence ofDnmt3awere recapitulated or enhanced by treatment with the demethylating agent 5-aza-2'-deoxycytidine as well as by down-modulation ofDnmt1expression, further supporting the role of DNA methylation in regulating mast cell activation. Mechanistically, these effects were in part mediated by the dysregulated expression of the scaffold protein IQGAP2, which is characterized by the ability to regulate a wide variety of biological processes. Altogether, our data demonstrate that DNMT3A and DNA methylation are key modulators of mast cell responsiveness to acute and chronic stimulation.
Institute for Research in Biomedicine, Università della Svizzera italiana (USI), 6500 Bellinzona, Switzerland.|Graduate School for Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland.
Cristina
C
Leoni
Institute for Research in Biomedicine, Università della Svizzera italiana (USI), 6500 Bellinzona, Switzerland.
Sara
S
Montagner
Lymphoma and Genomics Research Program, Institute of Oncology Research (IOR), USI, 6500 Bellinzona, Switzerland.
Andrea
A
Rinaldi
Lymphoma and Genomics Research Program, Institute of Oncology Research (IOR), USI, 6500 Bellinzona, Switzerland.|Oncology Institute of Southern Switzerland (IOSI), 6500 Bellinzona, Switzerland.
Francesco
F
Bertoni
Department of Experimental Oncology, European Institute of Oncology (IEO), 20139 Milan, Italy.
Sara
S
Polletti
Department of Experimental Oncology, European Institute of Oncology (IEO), 20139 Milan, Italy.
Chiara
C
Balestrieri
Institute for Research in Biomedicine, Università della Svizzera italiana (USI), 6500 Bellinzona, Switzerland; silvia.monticelli@irb.usi.ch.
Silvia
S
Monticelli
D000818:Animals; D001374:Azacitidine / Q000031:analogs & derivatives / Q000494:pharmacology; D015550:Cell Degranulation / Q000235:genetics; D049109:Cell Proliferation / Q000187:drug effects / Q000502:physiology*; D002478:Cells, Cultured; D000076123:DNA (Cytosine-5-)-Methyltransferase 1 / Q000378:metabolism; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000235:genetics / Q000378:metabolism*; D019175:DNA Methylation / Q000187:drug effects / Q000502:physiology*; D000090205:DNA Methyltransferase 3A; D000077209:Decitabine; D003877:Dermatitis, Contact / Q000209:etiology / Q000276:immunology*; D004195:Disease Models, Animal; D015536:Down-Regulation; D004797:Enzyme-Linked Immunosorbent Assay; D044127:Epigenesis, Genetic / Q000502:physiology*; D005260:Female; D005455:Fluorescent Antibody Technique; D007073:Immunoglobulin E / Q000276:immunology; D007377:Interleukin-3 / Q000378:metabolism; D008407:Mast Cells / Q000187:drug effects / Q000502:physiology*; D034721:Mastocytosis, Systemic / Q000276:immunology; D051379:Mice; D018345:Mice, Knockout; D009154:Mutation; D010081:Oxazolone / Q000633:toxicity; D010323:Passive Cutaneous Anaphylaxis / Q000276:immunology*; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000378:metabolism; D020703:ras GTPase-Activating Proteins / Q000235:genetics / Q000378:metabolism*
C000717967:DNMT3A protein, human; C000715535:Dnmt3a protein, mouse; D007377:Interleukin-3; C484416:Iqgap2 protein, mouse; D034741:RNA, Small Interfering; D020703:ras GTPase-Activating Proteins; D010081:Oxazolone; D007073:Immunoglobulin E; D000077209:Decitabine; D000076123:DNA (Cytosine-5-)-Methyltransferase 1; D004248:DNA (Cytosine-5-)-Methyltransferases; D000090205:DNA Methyltransferase 3A; C000619381:Dnmt1 protein, mouse; D001374:Azacitidine
DNA methylation; epigenetics; inflammation; mast cells